Heru develops patented AI-powered vision diagnostics and augmentation software that operates on commercially available AR/VR devices. This technology standardizes pretesting procedures in eye care, enhancing diagnostic accuracy and improving patient throughput in tele-optometry practices.
Funding
$36.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
DCFounders
Product
Problem
Traditional methods of pretesting in eye care can be inconsistent and may not accurately capture a patient's visual function. This can lead to diagnostic inaccuracies and inefficiencies in patient throughput, particularly in tele-optometry settings where standardized procedures are critical.
Solution
Heru develops AI-powered vision diagnostics and augmentation software that operates on commercially available augmented reality/virtual reality (AR/VR) devices. The company's EyeStream™ technology standardizes pretesting procedures in eye care, enhancing diagnostic accuracy and improving patient throughput. Heru's platform offers a portable and user-friendly means of testing visual fields, addressing the need for a more cost-effective and accessible solution, especially with the rise of telemedicine and the increasing prevalence of glaucoma worldwide. The technology is based on over 10 years of clinical research and development at the Bascom Palmer Eye Institute.
Target Audience
The primary target audience includes independent eye doctors, enterprise eye care providers, and telehealth practitioners seeking to improve diagnostic accuracy and patient throughput.
Features
- AI-powered algorithms for automated visual field testing and analysis
- Wearable AR/VR device integration for portable and convenient testing
- EyeStream™ technology to standardize pretesting procedures
- Tele-optometry applications to improve remote patient care
- Integration with existing eye care workflows and equipment